Fang Lei

Fang Lei

Auto-generated profile, based on publicly available information

Fang Lei

School of Pharmacy, Lanzhou University, Lanzhou 730000, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
QXQiang Xie
Qiang Xie
FLFengzhou Li
Fengzhou Li
LFLei Fang
Lei Fang
WLWenzhi Liu
Wenzhi Liu
CGChundong Gu
Chundong Gu
Inflammatory mediators and inflammatory cells in the inflammatory microenvironment promote the transformation of normal cells to cancer cells in the early stage of cancer, promote the growth and development of cancer cells, and induce tumor immune escape. The monomeric active ingredient β‐elemene is extracted from the traditional Chinese medicine Curcuma wenyujin and has been proven to have good anti‐inflammatory and antitumor activities in clinical applications for more than 20 years in China. Recent studies have found that this traditional Chinese medicine plays a vital role in macrophage infiltration and M2 polarization, as well as in regulating immune disorders, and it even regulates the transcription factors NF‐κB and STAT3 to alter inflammation, tumorigenesis, and development. In addition, β‐elemene regulates not only different inflammatory factors (such as TNF‐α, IFN, TGF‐β, and IL‐6/10) but also oxidative stress in vivo and in vitro. The excellent anti‐inflammatory and antitumor effects of β‐elemene and its ability to alter the inflammatory microenvironment of tumors have been gradually elaborated. Although the study of monomeric active ingredients in traditional Chinese medicines is insufficient in terms of quality and quantity, the pharmacological effects of more active ingredients of traditional Chinese medicines will be revealed after β‐elemene.

1 September 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
XFXiaohong Fan
Xiaohong Fan
JDJiedan Deng
Jiedan Deng
TSTao Shi
Tao Shi
HWHuaixiu Wen
Huaixiu Wen
JLJunfang Li
Junfang Li
ZWZhen Wang
Zhen Wang